Lithobid and Weight loss - a phase IV clinical study of FDA data

Summary:

Weight loss is reported as a side effect among people who take Lithobid (lithium carbonate), especially for people who are female, 30-39 old, also take Seroquel, and have Mood swings.

The phase IV clinical study analyzes which people have Weight loss when taking Lithobid. It is created by eHealthMe based on reports of 1,180 people who have side effects when taking Lithobid from the FDA, and is updated regularly.

What is Lithobid?

Lithobid has active ingredients of lithium carbonate. It is often used in bipolar disorder. eHealthMe is studying from 1,281 Lithobid users. Check the latest studies of Lithobid.

What is Weight loss?

Weight loss is found to be associated with 1,449 drugs and 2,293 conditions by eHealthMe. Check the latest studies of Weight loss.

On Jul, 15, 2026

1,180 people reported to have side effects when taking Lithobid.
Among them, 12 people (1.02%) have Weight loss.

Among these 12 people:

What is the gender of people who have Weight loss when taking Lithobid? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Weight loss when taking Lithobid? *

What are other drugs people take besides Lithobid? *

What are other side effects people have besides Weight loss? *

Type 2 Diabetes: 9 people, 75.00%
Diabetes Mellitus Inadequate Control: 4 people, 33.33%
Diabetes: 4 people, 33.33%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
High Blood Cholesterol: 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Memory Loss: 3 people, 25.00%
Sleep Apnea Syndrome: 2 people, 16.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 16.67%

What are the existing conditions these people have? *

Mood Swings (an extreme or rapid change in mood): 4 people, 33.33%
Sleep Disorder: 1 person, 8.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 8.33%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
Hiv Infection: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 8.33%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 1 person, 8.33%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lithobid and have Weight loss?

- Check whether Weight loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lithobid:

Lithobid (1,281 reports)

Weight loss treatments and more:

Weight loss (62,430 reports)

Browse all side effects of Lithobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight loss:

Weight loss (1,449 drugs)

Browse all the conditions that are associated with Weight loss:

Weight loss (2,293 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lithium carbonate (the active ingredients of Lithobid) and Lithobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.